Editas Medicine

Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases.

Gene Editing

CRISPR Technology

Genomic Medicine

Clinical Research

Rare Diseases

Cambridge, Middlesex County

201-500

2013年成立（第13年）

混合办公

Public

估值

$1.2B

融资总额

$300M

EDIT

$3.11

官网

招聘页面

博客

Editas Medicine在招职位

0个在招职位

目前没有在招职位

已关闭职位

1个职位

Join Our Team

Remote

已关闭 1个月前

产品与服务

reni-cel

Gene Therapy

EDIT-101

Gene Therapy

EDIT-301

Cell Therapy

CRISPR Gene Editing Platform

Technology Platform

EDIT-201

Gene Therapy

In Vivo Gene Editing Medicines

Gene Therapy

EDIT-103

Gene Therapy

In Vivo Gene Editing Services

R&D Services

CRISPR/Cas Gene Editing Platform

Platform Technology

Ex Vivo Cell Engineering

R&D Services

Ex Vivo Gene Editing Services

Research Services

Engineered Natural Killer (eNK) Cell Platform

Cell Therapy

EDIT-401

Gene Therapy

领导团队

Charlene Stern

Executive Vice President & General Counsel

Kevin Bitterman

Interim President

DRL

David R. Liu

Founder

Feng Zhang

Founder

相似公司

Bristol-Myers Squibb

Biopharmaceutical medicines for serious diseases

New York City, New York

10,001+人

Public

估值 $150B

383个在招职位

Mammoth Biosciences

Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington, our company’s ultracompact systems are…

Brisbane, San Mateo County

51-200人

Private

估值 $800M

Gilead Sciences

Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer & inflammation.

Foster City, San Mateo County

10,001+人

Public

估值 $85B

234个在招职位

Freenome

AI genomics company for cancer detection

South San Francisco, CA

201-500人

Private

估值 $2.3B

25个在招职位

Vir Biotechnology

Immunology-focused biotech

San Francisco, California

201-500人

Public

估值 $1.2B

11个在招职位